Quick Answer
BioRestorative Therapies, Inc. reported Stockholders Equity of $356.7 thousand for fiscal year 2025.
BioRestorative Therapies, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $356.7K | -95.8% |
| 2024 | $8.53M | -14.7% |
| 2023 | $10.00M | -2.8% |
| 2022 | $10.29M | -52.4% |
| 2021 | $21.60M | +1722.0% |
| 2020 | -$1.33M | +89.6% |
| 2019 | -$12.78M | -47.9% |
| 2018 | -$8.64M | -26.4% |
| 2017 | -$6.84M | -36.7% |
| 2016 | -$5.00M | -27.9% |
| 2015 | -$3.91M | +43.3% |
| 2014 | -$6.89M | -3.0% |
| 2013 | -$6.69M | -30.0% |
| 2012 | -$5.14M | -39.5% |
| 2011 | -$3.69M | -395.3% |
| 2010 | -$744.2K | -1356.8% |
| 2009 | -$51.1K | — |
| 2008 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.21M | -77.9% | -54.5% |
| June 30, 2025 | $4.85M | -55.1% | -21.1% |
| March 31, 2025 | $6.14M | -57.6% | -28.0% |
| December 31, 2024 | $8.53M | -14.7% | -14.6% |
| September 30, 2024 | $9.99M | -7.1% | -7.5% |
| June 30, 2024 | $10.80M | +308.3% | -25.5% |
| March 31, 2024 | $14.50M | +124.6% | +45.0% |
| December 31, 2023 | $10.00M | -2.8% | -7.0% |
- BioRestorative Therapies, Inc. showed a decrease of -95.8% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from BioRestorative Therapies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: